GP-532

N/A

Report date: 2025/05/30 15:59:53

Base Information

Drug NameGP-532
Drug Alias NameGP-532
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionToll like receptor 5 agonistsNuclear factor NF-kappa-B complex modulators
TargetsToll like receptor 5Nuclear factor NF-kappa-B complex
Therapy Area/IndicationsAcute Radiation Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEveron BiosciencesStatera Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenome Protection Inc
Active IndicationsN/A
Inactive IndicationsAcute Radiation Syndrome

Other Information

ATC CodeN/A
Related LinksN/A